Brief: China Biotech Services Holdings Says Sees Net Loss Of Not Less Than HK$45 Mln For HY
03/08/2020 12:01
Aug 3 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* SEES A NET LOSS OF NOT LESS THAN HK$45 MILLION FOR HY
* EXPECTED RESULT DUE TO DECREASE IN REVENUE FROM MEDICAL
LABORATORY TESTING AND HEALTH CHECK SERVICES SEGMENT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3vnVRG
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)